Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The VSports app下载. gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

Review
. 2021 Nov;110(5):987-998.
doi: 10.1002/JLB.3MR0121-277R. Epub 2021 Mar 30.

HMGB1: An overview of its roles in the pathogenesis of liver disease

Yuan-Ao Ni  1 , Hui Chen  1 , Hao Nie  1   2 , Bing Zheng  1   2 , Quan Gong  1   2
Affiliations
Review

HMGB1: An overview of its roles in the pathogenesis of liver disease

Yuan-Ao Ni et al. J Leukoc Biol. 2021 Nov.

Abstract

High-mobility group box 1 (HMGB1) is an abundant architectural chromosomal protein that has multiple biologic functions: gene transcription, DNA replication, DNA-damage repair, and cell signaling for inflammation. HMGB1 can be released passively by necrotic cells or secreted actively by activated immune cells into the extracellular milieu after injury. Extracellular HMGB1 acts as a damage-associated molecular pattern to initiate the innate inflammatory response to infection and injury by communicating with neighboring cells through binding to specific cell-surface receptors, including Toll-like receptors (TLRs) and the receptor for advanced glycation end products (RAGE) VSports手机版. Numerous studies have suggested HMGB1 to act as a key protein mediating the pathogenesis of chronic and acute liver diseases, including nonalcoholic fatty liver disease, hepatocellular carcinoma, and hepatic ischemia/reperfusion injury. Here, we provide a detailed review that focuses on the role of HMGB1 and HMGB1-mediated inflammatory signaling pathways in the pathogenesis of liver diseases. .

Keywords: HMGB1; RAGE; TLRs; liver disease; signaling pathway V体育安卓版. .

PubMed Disclaimer

"VSports在线直播" References

REFERENCES

    1. Kaswala DH, Lai M, Afdhal NH. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. Digest Dis Sci. 2016;61:1356-1364.
    1. Inkaya AC, Demir NA, Kolgelier S, et al. Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?. Medicine (Baltimore). 2017;96:e7547.
    1. Song L, Luo Y, Wang X, et al. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation. Mol Med Rep. 2019;20:4654-4664.
    1. Xie T, Li K, Gong X, et al. Paeoniflorin protects against liver ischemia/reperfusion injury in mice via inhibiting HMGB1-TLR4 signaling pathway. Phytother Res. 2018;32:2247-2255.
    1. Maxa M, Schaeper U, Dames S, Vollmar B, Kuhla A. Liver-specific Bid silencing inhibits APAP-induced cell death in mice. Apoptosis. 2019;24:934-945.

Publication types

"VSports最新版本" MeSH terms